Candriam S.C.A. Stryker Corp Transaction History

Candriam S.C.A.

$17.1 Billion
Q3 2024

A detailed history of Candriam S.C.A. transactions in Stryker Corp stock. As of the latest transaction made, Candriam S.C.A. holds 128,991 shares of SYK stock, worth $49.4 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

128,991

Previous 151,965 15.12%

Holding current value

$49.4 Million

Previous $51.7 Million 9.89%

% of portfolio

0.27%

Previous 0.32%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$315.94 - $371.96 $7.26 Million - $8.55 Million	-22,974 Reduced 15.12%	128,991 $46.6 Million
Q2 2024 Aug 05, 2024	SELL	$324.3 - $354.67 $12.7 Million - $13.8 Million	-39,030 Reduced 20.44%	151,965 $51.7 Million
Q1 2024 May 03, 2024	BUY	$293.94 - $358.71 $818,035 - $998,289	2,783 Added 1.48%	190,995 $68.4 Million
Q4 2023 Feb 14, 2024	BUY	$253.85 - $299.46 $14.7 Million - $17.3 Million	57,862 Added 44.39%	188,212 $56.4 Million
Q3 2023 Nov 13, 2023	BUY	$266.54 - $302.43 $1.22 Million - $1.39 Million	4,582 Added 3.64%	130,350 $35.6 Million
Q2 2023 Aug 08, 2023	SELL	$271.49 - $305.09 $8.07 Million - $9.07 Million	-29,718 Reduced 19.11%	125,768 $38.4 Million
Q1 2023 May 12, 2023	BUY	$246.13 - $285.47 $2.29 Million - $2.66 Million	9,305 Added 6.37%	155,486 $44.4 Million
Q4 2022 Feb 13, 2023	BUY	$205.51 - $253.93 $18.8 Million - $23.2 Million	91,477 Added 167.22%	146,181 $35.7 Million
Q3 2022 Nov 10, 2022	SELL	$189.27 - $231.83 $22.7 Million - $27.8 Million	-119,724 Reduced 68.64%	54,704 $11.1 Million
Q2 2022 Aug 03, 2022	SELL	$194.09 - $276.37 $2.74 Million - $3.91 Million	-14,141 Reduced 7.5%	174,428 $34.7 Million
Q1 2022 May 13, 2022	SELL	$245.33 - $277.77 $7.64 Million - $8.65 Million	-31,135 Reduced 14.17%	188,569 $50.4 Million
Q4 2021 Feb 10, 2022	BUY	$236.63 - $276.44 $3.4 Million - $3.97 Million	14,379 Added 7.0%	219,704 $58.8 Million
Q3 2021 Nov 09, 2021	BUY	$248.9 - $280.09 $10.3 Million - $11.6 Million	41,422 Added 25.27%	205,325 $54.1 Million
Q2 2021 Jul 20, 2021	BUY	$242.95 - $267.0 $31.9 Million - $35.1 Million	131,471 Added 405.37%	163,903 $42.6 Million
Q4 2020 Jan 22, 2021	SELL	$202.01 - $245.04 $2.3 Million - $2.8 Million	-11,407 Reduced 26.02%	32,432 $7.95 Million
Q3 2020 Oct 19, 2020	SELL	$177.77 - $215.81 $181,503 - $220,342	-1,021 Reduced 2.28%	43,839 $9.13 Million
Q2 2020 Jul 23, 2020	SELL	$144.67 - $207.03 $1.65 Million - $2.37 Million	-11,439 Reduced 20.32%	44,860 $8.08 Million
Q4 2019 Jan 21, 2020	SELL	$197.98 - $220.53 $218,569 - $243,465	-1,104 Reduced 1.92%	56,299 $12,000
Q3 2019 Feb 05, 2020	SELL	$205.4 - $221.82 $1,232 - $1,330	-6 Reduced 0.01%	57,403 $12.4 Million
Q3 2019 Oct 21, 2019	SELL	$205.4 - $221.82 $2.46 Million - $2.66 Million	-11,992 Reduced 17.28%	57,409 $13,000
Q2 2019 Aug 01, 2019	BUY	$180.24 - $205.58 $924,450 - $1.05 Million	5,129 Added 7.98%	69,401 $15.2 Million
Q1 2019 May 02, 2019	BUY	$152.46 - $198.0 $87,816 - $114,048	576 Added 0.9%	64,272 $12.7 Million
Q4 2018 Feb 14, 2019	BUY	$145.0 - $178.65 $100,630 - $123,983	694 Added 1.1%	63,696 $9.98 Million
Q3 2018 Nov 07, 2018	SELL	$163.25 - $177.68 $50,117 - $54,547	-307 Reduced 0.48%	63,002 $11.2 Million
Q2 2018 Aug 14, 2018	BUY	$155.17 - $179.78 $56,481 - $65,439	364 Added 0.58%	63,309 $10.7 Million
Q1 2018 May 09, 2018	BUY	$148.01 - $168.91 $170,063 - $194,077	1,149 Added 1.86%	62,945 $10.1 Million
Q4 2017 Feb 07, 2018	BUY	$143.51 - $159.74 $2.01 Million - $2.24 Million	14,000 Added 29.29%	61,796 $9.57 Million
Q3 2017 Nov 03, 2017	BUY	$138.36 - $147.87 $6.61 Million - $7.07 Million	47,796	47,796 $6.79 Million

Others Institutions Holding SYK

# of Institutions

2,221

Shares Held

285M

Call Options Held

1.19M

Put Options Held

1.56M

View Full List

About STRYKER CORP

Ticker SYK
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 378,320,992
Market Cap $145B
Description
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...

More about SYK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.

Account